UNSPSC 51113204: Meturedepa
Commodity
Code facts
- Part of
-
-
51000000
-
51110000
- 51113200
-
51110000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51113204
| NIGP code |
|---|
| 26910 Antineoplastic Agents |
Definition
This classification denotes an ethylenimine compound with the molecular formula C11H22N3O3P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 43255365IF, chemically known as ethyl n-(bis(2,2-dimethylethylenimido)phosphoro)carbamate but more generally known as meturedepa, which bears US NIH Compound Identifier 15456. European Medicines Agency schedules Meturedepa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08923MIG. The term METUREDEPA is an International Non-Proprietary Name.
Read the full definition
METUREDEPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule meturedepa under HS 29339990 and SITC 51577. As of Q4 2014, METUREDEPA remains US FDA's Preferred Term for this commodity. Meturedepa bears US NLM identifiers UMLS ID C0609940 and NCI Concept Code C1760. SMILES: CCOC(=O)NP(=O)(N1CC1(C)C)N2CC2(C)C.
About UNSPSC 51113204
UNSPSC 51113204 Meturedepa is a Commodity code covering pharmaceutical products and related pharmacy benefit program services that state and local governments procure to support prescription management and drug distribution. The code captures work ranging from direct pharmaceutical sourcing and pharmacy benefit management to therapeutic initiatives that reshape how state agencies fulfill prescription obligations and negotiate drug pricing outside traditional wholesale and pharmacy benefit manager channels. State health and human services agencies are the primary issuing bodies under this code, soliciting vendor capabilities and implementation services for pharmacy programs that serve state employee health plans, Medicaid populations, and public retirees.
The Texas Health and Human Services Commission posted a Request for Information (RFI HHS0017013) on April 3, 2026, seeking vendor input on establishing a Therapeutic Pharmacy Initiative (TPI) Direct-to-Manufacturer Prescriptions program. The RFI requested information from vendors experienced in direct contracting with self-insured employers and government health plans within the prior two years, with emphasis on negotiated net pricing models, value-based agreements, and fulfillment strategies outside existing pharmacy benefit manager and group purchasing organization arrangements. The state intends to use vendor responses to inform a subsequent formal Request for Proposal with established pricing and contract terms. Texas represents the recent activity visible under this code; no other state or local opportunities appear in the current record.
Quick answers
What is UNSPSC 51113204?
UNSPSC 51113204 is Meturedepa, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51113204?
UNSPSC 51113204 maps to 1 NIGP code, 26910 Antineoplastic Agents.
On GovTribe
See everything under UNSPSC 51113204
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code